로그인

Universitatsklinikum Hamburg-Eppendorf

2 ARTICLES PUBLISHED IN JoVE

image

Medicine

Invasive Hemodynamic Monitoring of Aortic and Pulmonary Artery Hemodynamics in a Large Animal Model of ARDS
Rahel Kluttig 1, Till Friedheim 1, Christoph Behem 1, Niko Zach 1, Rosannis Brown 1, Michael Graessler 1, Daniel Reuter 1, Christian Zöllner 1, Constantin Trepte 1
1Universitatsklinikum Hamburg-Eppendorf

We present a protocol of creating right ventricular dysfunction in a pig model by inducing ARDS. We demonstrate invasive monitoring of left and right ventricular cardiac output using flow probes around the aorta and the pulmonary artery, as well as blood pressure measurements in the aorta and pulmonary artery.

image

Medicine

Real-Time Assessment of Spinal Cord Microperfusion in a Porcine Model of Ischemia/Reperfusion
Christoph R. Behem 1, Till Friedheim 1, Sabine H. Wipper 2, Hans O. Pinnschmidt 3, Michael F. Graessler 1, Catharina Gaeth 4, Hannes Holthusen 1, Adina Rapp 5, Timo Suntrop 1, Josephina Haunschild 6, Christian D. Etz 6, Constantin J. C. Trepte 1
1Department of Anesthesiology, Center of Anesthesiology and Intensive Care Medicine, University Medical Center Hamburg-Eppendorf, 2University Department for Vascular Surgery and Department of Operative Medicine, Medical University of Innsbruck, 3Department of Medical Biometry and Epidemiology, University Medical Center Hamburg-Eppendorf, 4Department of Vascular Medicine, University Heart and Vascular Center Hamburg (UHZ), 5Department of Cardiology, Rostock University Medical Center, 6University Department for Cardiac Surgery, Heart Center Leipzig

Spinal cord microcirculation plays a pivotal role in spinal cord injury. Most methods do not allow real-time assessment of spinal cord microcirculation, which is essential for the development of microcirculation-targeted therapies. Here, we propose a protocol using Laser-Doppler-Flow Needle probes in a large animal model of ischemia/reperfusion.

JoVE Logo

개인 정보 보호

이용 약관

정책

연구

교육

JoVE 소개

Copyright © 2024 MyJoVE Corporation. 판권 소유